TY - JOUR
T1 - Global Perspectives on Immunization Against SARS-CoV-2 During Pregnancy and Priorities for Future Research
T2 - An International Consensus Paper From the World Association of Infectious Diseases and Immunological Disorders
AU - Abu-Raya, Bahaa
AU - Madhi, Shabir A.
AU - Omer, Saad B.
AU - Amirthalingam, Gayatri
AU - Giles, Michelle L.
AU - Flanagan, Katie L.
AU - Zimmermann, Petra
AU - O’Ryan, Miguel
AU - Safadi, Marco A.
AU - Papaevangelou, Vassiliki
AU - Maertens, Kirsten
AU - Wanlapakorn, Nasamon
AU - Diaz-Brito, Vicens
AU - Tommelein, Eline
AU - Esposito, Susanna
N1 - Funding Information:
The publication of this manuscript was supported by the World Association for Infectious Diseases and Immunological Disorders (WAidid).
Publisher Copyright:
Copyright © 2021 Abu-Raya, Madhi, Omer, Amirthalingam, Giles, Flanagan, Zimmermann, O’Ryan, Safadi, Papaevangelou, Maertens, Wanlapakorn, Diaz-Brito, Tommelein and Esposito.
PY - 2021/12/23
Y1 - 2021/12/23
N2 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of countries recommend immunization against SARS-CoV-2 in pregnant women. Recent studies provide preliminary and supportive evidence on safety, immunogenicity and effectiveness of coronavirus disease 2019 (COVID-19) vaccines in pregnant women; however, important knowledge gaps remain which warrant further studies. This collaborative consensus paper provides a review of the current literature on COVID-19 vaccines in pregnant women, identifies knowledge gaps and outlines priorities for future research to optimize protection against SARS-CoV-2 in the pregnant women and their infants.
AB - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pregnancy is associated with a higher risk for severe morbidity and mortality when compared with infection in non-pregnant women of childbearing age. An increasing number of countries recommend immunization against SARS-CoV-2 in pregnant women. Recent studies provide preliminary and supportive evidence on safety, immunogenicity and effectiveness of coronavirus disease 2019 (COVID-19) vaccines in pregnant women; however, important knowledge gaps remain which warrant further studies. This collaborative consensus paper provides a review of the current literature on COVID-19 vaccines in pregnant women, identifies knowledge gaps and outlines priorities for future research to optimize protection against SARS-CoV-2 in the pregnant women and their infants.
KW - COVID-19
KW - maternal immunization
KW - maternal vaccination program
KW - pregnant women
KW - SARS-CoV-2
UR - http://www.scopus.com/inward/record.url?scp=85122478108&partnerID=8YFLogxK
U2 - 10.3389/fimmu.2021.808064
DO - 10.3389/fimmu.2021.808064
M3 - Review Article
C2 - 35003137
AN - SCOPUS:85122478108
SN - 1664-3224
VL - 12
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 808064
ER -